MedicarePartD.guide

A non-government resource built from CMS public data

EXJADE 250 mg Tablet, For Suspension

Also known as Deferasirox. Coverage in Connecticut, Massachusetts, Rhode Island and Vermont (CMS PDP Region 02).

Not on any stand-alone Part D formulary in Connecticut, Massachusetts, Rhode Island and Vermont

None of the 11 stand-alone Part D (PDP) plans in CMS PDP Region 02 list this drug. On one of those plans the patient would pay the full retail price, or you would need a formulary exception.

See coverage in all 39 regions →